KAI MEDTECH

KAI MEDTECH was founded in 2019, focusing on the research, production, and sales of neurointerventional medical device products, with a product pipeline that fully covers hemorrhagic, ischemic, and access categories. KAI MEDTECH is committed to using neurointervention as an entry point, driven by the dual engines of strong "independent R&D capabilities + global advanced technology BD capabilities," as well as a complete R&D–product–market sales closed-loop system, to become a leading innovative technology platform in the global cerebrovascular disease device industry, and even the entire medical device industry. Since its establishment, KAI MEDTECH has been dedicated to building an international platform for underlying neurointervention technologies. To date, it has fully completed the construction of catheter, guidewire, and balloon technology platforms, with the stent technology platform nearing completion. The establishment of these underlying technology platforms has facilitated the rapid R&D and iteration of new products for the company.